Hospira Demerol ampoules missing label - recall for safety

Take action

Contact the company & request your remedy

Recalling firmHospira Inc.275 N Field Dr, N/A · Lake Forest, IL 60045-2579

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Hospira is recalling Demerol injection ampoules that lack the required container label. This missing label could lead to incorrect use or dosing errors, especially since the product is prescription-only.

Why it’s dangerous

The ampoules are missing the immediate container label, which is critical for safe administration. Without this label, healthcare professionals might not know the correct dosage or concentration, leading to potential dosing errors. This is a labeling issue that could affect patient safety during medical procedures.

Who’s affected

Prescription patients using Demerol injections from Hospira. Healthcare providers who dispense these medications are most at risk due to potential dosing errors.

How to tell if you have this one

Check for Demerol 25 mg/0.5 mL (50 mg/mL) ampoules with NDC 0409-1203-01. The product was sold with lot number 221303A, manufactured in October 2014.

Brand
Hospira
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for the missing container label on the Demerol ampoules. If the label is missing, stop using the product.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product is not safe to use as it lacks the required container label, which could lead to dosing errors. Do not use the product until you confirm the label is present.

How can I check if my product is affected?

Check for Demerol 25 mg/0.5 mL (50 mg/mL) ampoules with NDC 0409-1203-01 and lot number 221303A, manufactured in October 2014.

What should I do if I have the recalled product?

If you have the recalled product, stop using it and contact Hospira for further instructions.

Take action

Contact Hospira

We’ve drafted a message you can send Hospira to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-1226-2014 — Hospira Hospira

Hello,

I own a Hospira that is covered by recall D-1226-2014 from Hospira.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1226-2014 (March 25, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1226-2014 to see it in context.
Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Hospira Inc. recalls Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc.,

Lower-risk recall